ERBB2 and neoplasm: For the malignant disease group, the association between the level of ccf DNA and other established clinical parameters, including tumor size, lymph node involvement, extent of metastasis and the status of estrogen receptor (ER), progesterone receptor (PR) and Her2/neu were analyzed.